Published in Retina on June 01, 2004
Optimal management of cytomegalovirus retinitis in patients with AIDS. Clin Ophthalmol (2010) 1.08
Immune recovery uveitis: pathogenesis, clinical symptoms, and treatment. Mediators Inflamm (2014) 0.76
Immune recovery uveitis in HIV patients with cytomegalovirus retinitis in the era of HAART therapy-a 5-year study from Singapore. J Ophthalmic Inflamm Infect (2016) 0.75
Ophthalmologic Disease in HIV Infection: Recent Changes in Pathophysiology and Treatment. Curr Infect Dis Rep (2017) 0.75
Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology (1985) 3.83
Cytomegalovirus retinitis and acquired immunodeficiency syndrome. Arch Ophthalmol (1989) 2.18
Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis. Am J Ophthalmol (1998) 1.83
Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol (1993) 1.82
Immune recovery vitritis associated with inactive cytomegalovirus retinitis: a new syndrome. Arch Ophthalmol (1998) 1.73
Immune recovery vitritis and uveitis in AIDS: clinical predictors, sequelae, and treatment outcomes. Retina (2001) 1.53
Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Am J Ophthalmol (2002) 1.48
Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression. Arch Ophthalmol (1996) 1.42
Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy. Am J Ophthalmol (2000) 1.41
Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy. J Infect Dis (1999) 1.39
Long-term posterior and anterior segment complications of immune recovery uveitis associated with cytomegalovirus retinitis. Am J Ophthalmol (2000) 1.33
Treatment of immune recovery vitritis with local steroids. Br J Ophthalmol (1999) 1.02
Association between immune recovery uveitis and a diverse intraocular cytomegalovirus-specific cytotoxic T cell response. J Infect Dis (2002) 0.99
Treatment with corticosteroids--a risk factor for the development of clinical cytomegalovirus disease in AIDS. AIDS (1993) 0.96
Vitreomacular traction syndrome following highly active antiretroviral therapy in AIDS patients with cytomegalovirus retinitis. Retina (1998) 0.89
Immune recovery uveitis. Am J Ophthalmol (2000) 0.85
Ketorolac treatment of pseudophakic cystoid macular edema identified more than 24 months after cataract extraction. Ophthalmology (1999) 0.83
Cytomegalovirus retinitis in the era of highly active antiretroviral therapy. JAMA (2000) 0.82
Immune recovery uveitis. Hopkins HIV Rep (2001) 0.80
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology (2006) 10.18
Porous silicon in drug delivery devices and materials. Adv Drug Deliv Rev (2008) 3.43
Carotid artery intima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure. AIDS (2005) 3.07
Changes of intraocular pressure after intravitreal injection of bevacizumab (avastin). Retina (2007) 2.15
The role of abnormal vitreomacular adhesion in age-related macular degeneration: spectral optical coherence tomography and surgical results. Am J Ophthalmol (2008) 2.10
HORIZON: an open-label extension trial of ranibizumab for choroidal neovascularization secondary to age-related macular degeneration. Ophthalmology (2012) 1.82
Discrepancy between fluorescein angiography and optical coherence tomography in detection of macular disease. Retina (2008) 1.78
Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults. AIDS (2007) 1.78
Intraocular and systemic pharmacokinetics of triamcinolone acetonide after a single 40-mg posterior subtenon application. Ophthalmology (2010) 1.64
The association between percent disruption of the photoreceptor inner segment-outer segment junction and visual acuity in diabetic macular edema. Am J Ophthalmol (2010) 1.63
Intravitreal toxicity of the kenalog vehicle (benzyl alcohol) in rabbits. Retina (2006) 1.61
Valganciclovir therapy for immune recovery uveitis complicated by macular edema. Am J Ophthalmol (2004) 1.57
Results of silicone oil removal in patients with cytomegalovirus retinitis related retinal detachments. Am J Ophthalmol (2005) 1.56
Complex microcirculation patterns detected by confocal indocyanine green angiography predict time to growth of small choroidal melanocytic tumors: MuSIC Report II. Ophthalmology (2002) 1.52
Comparison of visual acuity in macular degeneration patients measured with snellen and early treatment diabetic retinopathy study charts. Ophthalmology (2007) 1.51
Clinical evaluation and treatment accuracy in diabetic macular edema using navigated laser photocoagulator NAVILAS. Ophthalmology (2011) 1.49
Incidence of and risk factors for clinically significant methicillin-resistant Staphylococcus aureus infection in a cohort of HIV-infected adults. J Acquir Immune Defic Syndr (2005) 1.47
Choroidal volume variations with age, axial length, and sex in healthy subjects: a three-dimensional analysis. Ophthalmology (2012) 1.46
Visual outcomes after wavefront-guided laser in situ keratomileusis with and without iris registration. J Cataract Refract Surg (2008) 1.42
Correlation between morphologic features on spectral-domain optical coherence tomography and angiographic leakage patterns in macular edema. Retina (2010) 1.39
A randomized trial of the efficacy and safety of fenofibrate versus pravastatin in HIV-infected subjects with lipid abnormalities: AIDS Clinical Trials Group Study 5087. AIDS Res Hum Retroviruses (2005) 1.37
HIV-associated retinopathy in the HAART era. Retina (2005) 1.27
Optical coherence tomography-raster scanning and manual segmentation in determining drusen volume in age-related macular degeneration. Retina (2010) 1.26
Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis. Ophthalmology (2006) 1.20
External limiting membrane as a predictor of visual improvement in diabetic macular edema after pars plana vitrectomy. Graefes Arch Clin Exp Ophthalmol (2012) 1.16
Avastin and new treatments for AMD: where are we? Retina (2006) 1.15
Correlation between spectral-domain optical coherence tomography and fundus autofluorescence at the margins of geographic atrophy. Am J Ophthalmol (2009) 1.13
Characterization of a novel intraocular drug-delivery system using crystalline lipid antiviral prodrugs of ganciclovir and cyclic cidofovir. Invest Ophthalmol Vis Sci (2004) 1.12
Repeatability and reproducibility of manual choroidal volume measurements using enhanced depth imaging optical coherence tomography. Invest Ophthalmol Vis Sci (2012) 1.10
Treatment or prevention of herpes simplex virus retinitis with intravitreally injectable crystalline 1-O-hexadecylpropanediol-3-phospho-ganciclovir. Invest Ophthalmol Vis Sci (2002) 1.10
Assessing susceptibility to age-related macular degeneration with genetic markers and environmental factors. Arch Ophthalmol (2011) 1.10
Multifocal electroretinography in HIV-positive patients without infectious retinitis. Am J Ophthalmol (2008) 1.08
Objective analysis of retinal damage in HIV-positive patients in the HAART era using OCT. Am J Ophthalmol (2005) 1.08
Combined depth imaging technique on spectral-domain optical coherence tomography. Am J Ophthalmol (2012) 1.07
Correspondence. Retina (2015) 1.06
Real-time monitoring of sustained drug release using the optical properties of porous silicon photonic crystal particles. Biomaterials (2010) 1.05
Characterization of diabetic microaneurysms by simultaneous fluorescein angiography and spectral-domain optical coherence tomography. Am J Ophthalmol (2012) 1.05
Ocular pharmacokinetics of bevacizumab in vitrectomized eyes with silicone oil tamponade. Invest Ophthalmol Vis Sci (2012) 1.04
Sphingomonas paucimobilis bloodstream infections associated with contaminated intravenous fentanyl. Emerg Infect Dis (2009) 1.04
The impact of macular edema on visual function in intermediate, posterior, and panuveitis. Ocul Immunol Inflamm (2012) 1.03
Imaging of long-term retinal damage after resolved cotton wool spots. Ophthalmology (2009) 1.02
Scanning laser ophthalmoscope imaging stabilized microperimetry in dry age-related macular degeneration. Retina (2011) 1.02
Navigated macular laser decreases retreatment rate for diabetic macular edema: a comparison with conventional macular laser. Clin Ophthalmol (2013) 1.02
Intravitreal crystalline drug delivery for intraocular proliferation diseases. Invest Ophthalmol Vis Sci (2009) 1.01
Risk factors for hepatic decompensation in patients with HIV/HCV coinfection and liver cirrhosis during interferon-based therapy. AIDS (2004) 1.01
Lidocaine gel anesthesia for intravitreal drug administration. Retina (2005) 1.01
Spectral domain optical coherence tomography for imaging ERM, retinal edema, and vitreomacular interface. Retina (2010) 1.00
Paradoxical activity of CMV retinitis in patients receiving highly active antiretroviral therapy. Retina (2002) 1.00
Oxidized porous silicon particles covalently grafted with daunorubicin as a sustained intraocular drug delivery system. Invest Ophthalmol Vis Sci (2013) 0.99
Machine learning classifiers detect subtle field defects in eyes of HIV individuals. Trans Am Ophthalmol Soc (2007) 0.97
Viral retinitis after intravitreal triamcinolone injection in patients with predisposing medical comorbidities. Am J Ophthalmol (2010) 0.97
Effect of baseline CD4 cell count on the efficacy and safety of peginterferon Alfa-2a (40KD) plus ribavirin in patients with HIV/hepatitis C virus coinfection. J Acquir Immune Defic Syndr (2008) 0.97
Focal navigated laser photocoagulation in retinovascular disease: clinical results in initial case series. Retina (2012) 0.96
Combined depth imaging using optical coherence tomography as a novel imaging technique to visualize vitreoretinal choroidal structures. Retina (2013) 0.94
Effect of anti-cytomegalovirus therapy on the incidence of immune recovery uveitis in AIDS patients with healed cytomegalovirus retinitis. Am J Ophthalmol (2003) 0.94
Lipoprotein Changes in HIV-Infected Antiretroviral-Naïve Individuals after Starting Antiretroviral Therapy: ACTG Study A5152s Stein: Lipoprotein Changes on Antiretroviral Therapy. J Clin Lipidol (2008) 0.94
Prophylactic intraoperative 360 degrees laser retinopexy for prevention of retinal detachment. Retina (2007) 0.94
Characterisation of systemic and ocular drug level of triamcinolone acetonide following a single sub-Tenon injection. Br J Ophthalmol (2010) 0.93
Hyperreflective sign in resolved cotton wool spots using high-resolution optical coherence tomography and optical coherence tomography ophthalmoscopy. Ophthalmology (2007) 0.93
A degenerative retinal process in HIV-associated non-infectious retinopathy. PLoS One (2013) 0.92
Toxicity and intraocular properties of a novel long-acting anti-proliferative and anti-angiogenic compound IMS2186. Curr Eye Res (2008) 0.92
Characterization of microaneurysm closure after focal laser photocoagulation in diabetic macular edema. Am J Ophthalmol (2013) 0.92
Intravitreal triamcinolone acetonide for the treatment of immune recovery uveitis macular edema. Ophthalmology (2007) 0.91
Observations by spectral-domain optical coherence tomography combined with simultaneous scanning laser ophthalmoscopy: imaging of the vitreous. Am J Ophthalmol (2010) 0.90
Characteristics and outcomes of choroidal neovascularization occurring after macular hole surgery. Retina (2004) 0.90
Predictors of visual outcome in eyes with choroidal neovascularization secondary to age related macular degeneration treated with intravitreal bevacizumab monotherapy. Int J Ophthalmol (2013) 0.89
Evaluation of the toxicity of subretinal triamcinolone acetonide in the rabbit. Retina (2006) 0.89
Scanning laser polarimetry demonstration of retinal nerve fiber layer damage in human immunodeficiency virus-positive patients without infectious retinitis. Retina (2007) 0.89